Literature DB >> 30778846

The Effect of Gastric Bypass with a Distal Gastric Pouch on Glucose Tolerance and Diabetes Remission in Type 2 Diabetes Sprague-Dawley Rat Model.

Ponnie Robertlee Dolo1,2, Yong Shao1,2, Chao Li1,2, Xiaocheng Zhu3,4, Libin Yao1,2, Hui Wang1,2.   

Abstract

BACKGROUND: Gastric bypass with a proximal gastric pouch (Roux-en-Y gastric bypass) induces early diabetes remission. The effect of gastric bypass with a distal gastric pouch remains unknown.
OBJECTIVE: To observe the effect on glucose tolerance and diabetes remission of gastric bypass with a distal gastric pouch.
METHOD: A type 2 diabetes (T2D) model was created in 44 Sprague-Dawley (SD) rats that randomly underwent Roux-en-Y gastric bypass (RYGB, n = 8); gastric bypass with duodenal-jejunal transit (GB-DJT, n = 8); distal-pouch gastric bypass with duodenal-jejunal transit (DPGB-DJT, n = 8); distal-pouch gastric bypass with duodenal-jejunal bypass (DPGB-DJB, n = 8); sham (n = 6); and Roux-en-Y gastric bypass with esophageal re-anastomosis (RYGB-Er, n = 6) surgery. In the DPGB-DJT and the DPGB-DJB groups, the gastric pouch was created in the distal stomach. In the RYGB and the GB-DJT groups, the gastric pouch was created in the proximal stomach. An oral glucose tolerance test (OGTT), insulin tolerance test (ITT) and mixed-meal tolerance test (MMTT) conducted preoperatively were repeated postoperatively.
RESULTS: GLP-1 AUC recorded preoperatively was significantly increased 8 weeks postoperatively in the RYGB, GB-DJT, and DPGB-DJB groups. Increased GLP-1 AUC in the DPGB-DJT did not reach statistical significance. Improved glucose tolerance in the RYGB and GB-DJT groups was significantly higher than DPGB-DJT group. DPGB-DJB did not improve glucose tolerance significantly. Gastrin level was increased significantly in the DPGB-DJT and DPGB-DJB groups.
CONCLUSION: In gastric bypass, creating the gastric pouch in the distal region of the stomach significantly impairs the glucose tolerance and diabetes remission in spite of the increased GLP-1 and insulin responses in T2D SD rat model, suggesting that bypassing the distal stomach may be the key mediator of early diabetes remission after RYGB.

Entities:  

Keywords:  Distal stomach, antrum; Duodenal-jejunal bypass; Foregut; GLP-1; Gastric bypass; Gastrin; Type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 30778846     DOI: 10.1007/s11695-019-03776-w

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  28 in total

Review 1.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

Review 2.  The gut sensor as regulator of body weight.

Authors:  Thomas Reinehr; Christian L Roth
Journal:  Endocrine       Date:  2014-12-30       Impact factor: 3.633

3.  Metabolic Effect of Foregut Exclusion Demonstrated by the Impact of Gastrogastric Fistula on Recurrence of Diabetes.

Authors:  Pichamol Jirapinyo; Andrew C Thompson; Paul T Kröner; Walter W Chan; Christopher C Thompson
Journal:  J Am Coll Surg       Date:  2017-12-22       Impact factor: 6.113

4.  Is gastrin partially responsible for body weight reduction after gastric bypass?

Authors:  Björn Stenstrom; Chun-Mei Zhao; Karin Tømmerås; Carl-Jørgen Arum; Duan Chen
Journal:  Eur Surg Res       Date:  2006-04-25       Impact factor: 1.745

5.  Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes.

Authors:  Emmanuel E Zervos; Steven C Agle; Alex J Warren; Christina G Lang; Timothy L Fitzgerald; Moahad Dar; Michael F Rotondo; Walter J Pories
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

Review 6.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

7.  Gastrin Secretion After Bariatric Surgery-Response to a Protein-Rich Mixed Meal Following Roux-En-Y Gastric Bypass and Sleeve Gastrectomy: a Pilot Study in Normoglycemic Women.

Authors:  Eivind Grong; Hallvard Græslie; Bjørn Munkvold; Ingerid Brænne Arbo; Bård Erik Kulseng; Helge L Waldum; Ronald Mårvik
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

8.  The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model.

Authors:  Ming Zhang; Xiao-Yan Lv; Jing Li; Zhi-Gang Xu; Li Chen
Journal:  Exp Diabetes Res       Date:  2009-01-04

9.  Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes.

Authors:  Roland E Allen; Tyler D Hughes; Jia Lerd Ng; Roberto D Ortiz; Michel Abou Ghantous; Othmane Bouhali; Philippe Froguel; Abdelilah Arredouani
Journal:  Theor Biol Med Model       Date:  2013-07-13       Impact factor: 2.432

10.  Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.

Authors:  George Tharakan; Preeshila Behary; Nicolai J Wewer Albrechtsen; Harvinder Chahal; Julia Kenkre; Alexander D Miras; Ahmed R Ahmed; Jens J Holst; Stephen R Bloom; Tricia Tan
Journal:  Eur J Endocrinol       Date:  2017-08-30       Impact factor: 6.664

View more
  1 in total

1.  Effect of sleeve gastrectomy, Roux-en-Y gastric bypass, and ileal transposition on myocardial ischaemia-reperfusion injury in non-obese non-diabetic rats.

Authors:  Oleg Kornyushin; Dmitry Sonin; Alexander Polozov; Vitaly Masley; Nika Bulavinova; Maria Chervyak; Maria Istomina; Daria Mukhametdinova; Alexander Neimark; Yuri Cheburkin; Yana Toropova; Kira Derkach; Alexander Shpakov; Michael Galagudza; Evgenyi Shlyakhto
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.